Lee et al., in 2014, demonstrated that Raftlin is related to the severity of sepsis and the dysfunction of endothelial cells, using not only prospective studies but also in vitro/in vivo studies as well, suggesting that Raftlin could be used as a biomarker for determining the severity of sepsis [12]. This evidence concerns the gene RFTN1 and Sepsis.